News | Radiation Therapy | December 13, 2016

ASTRO Announces Elekta Support for Radiation Oncology Safety and Quality Initiative

Radiation Oncology Incident Learning System provides online portal for RO centers to record non-patient-specific data about safety incidents

ASTRO, Elekta, RO-ILS, Radiation Oncology Incident Learning System, dose safety

December 13, 2016 — The American Society for Radiation Oncology (ASTRO) announced in November that Elekta has provided signficant financial support to RO-ILS: Radiation Oncology Incident Learning System a national patient safety initiative launched in 2014 by ASTRO and the American Association of Physicists in Medicine (AAPM). RO-ILS facilitates safer and higher quality care in radiation oncology by providing a mechanism for shared learning in a secure and non-punitive environment. It is the only medical specialty society-sponsored radiation oncology incident learning system within a federally listed Patient Safety Organization (PSO).

RO-ILS is an online portal for radiation oncology centers to record non-patient-specific data about safety incidents and near-misses related to radiation therapy that occur at their facilities. To date, a total of 224 radiation therapy facilities from 36 different states have submitted nearly 2,500 events to the PSO. Clarity PSO and the Radiation Oncology Healthcare Advisory Council (RO-HAC), a panel of experts in radiation oncology, work together to aggregate, analyze and interpret the data submitted into RO-ILS. Quarterly published reports educate the radiation oncology community about how to improve safety and patient care. There are no fees for centers to participate in RO-ILS, an aspect of the program that the gift from Elekta will help preserve.

“The support from Elekta will help us keep this initiative free for participating radiation oncology centers, which preserves access to RO-ILS and encourages more centers, both large and small, to join this nationwide safety effort,” said David C. Beyer, M.D., FASTRO, chair of ASTRO’s Board of Directors. “Additionally, this gift allows us to conduct more in-depth data analysis by increasing the number of members on the Radiation Oncology Healthcare Advisory Council (RO-HAC).”

For more information: www.astro.org

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more